Weil advised the underwriters in connection with Zimmer Biomet Holdings, Inc.’s $1.75 billion notes offering, consisting of its (i) $600 million aggregate principal amount of 4.700% notes due 2027, (ii) $550 million aggregate principal amount of 5.050% notes due 2030 and (iii) $600 million aggregate principal amount of 5.500% notes due 2035. The proceeds will be used for the Paragon 28 merger and any remaining amounts will be used for general corporate purposes, including repayment of indebtedness. Founded in 1927, Zimmer Biomet is a global medical technology leader offering innovative implants and digital technologies across all stages of the patient journey.
The Weil deal team was led by Capital Markets Co-Head Michael Hickey and included Capital Markets associates Michael Cremers, Zachary Fialkow and Alex Hansen; Tax partner Graham Magill and associate Madeline Joerg; and Regulatory partner Timothy Welch.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
